Tina K. Schlafly

Also affiliated with Corcept Therapeutics (United States)

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes”.

Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes

Diabetes Care(2025)10.2337/dc24-2841

N/A

0.510DataRank · unranked

29 citations

Steven E. Kahn, Vanita R. Aroda, Richard J. Auchus, Timothy S. Bailey, Irina Bancos +79 more

Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment

Diabetes Care(2025)10.2337/dc25-1055

N/A

0DataRank · unranked

17 citations

Vivian Fonseca, Vanita R. Aroda, Richard J. Auchus, Timothy S. Bailey, Irina Bancos +78 more

Prevalence of Hypercortisolism in Patients with Difficult-to-control Type 2 Diabetes: Final Results from CATALYST Part 1

Metabolism(2025)10.1016/j.metabol.2025.156211

N/A

0DataRank · unranked

0 citations

Steven E. Kahn, Vanita R. Aroda, Richard J. Auchus, Timothy S. Bailey, Irina Bancos +21 more